The client’s voice: why they consistently choose Kayentis
At Kayentis, client satisfaction isn’t just a goal—it’s our standard. We pride ourselves on delivering
Ophthalmology Clinical Trials
Ophthalmic conditions and vision impairment currently affect 2.2 billion people globally.
Kayentis offers tailored decentralized solutions with qualitative ePROs and extensive experience in ophthalmology to ensure the success of ophthalmology clinical trials by:
Learn more in the case study:
Learn more:
At Kayentis, client satisfaction isn’t just a goal—it’s our standard. We pride ourselves on delivering
At Kayentis, we value each individual and we form a community that goes beyond the
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of
Last update : 7 March 2024